Christopher C Parker

Christopher C Parker

UNVERIFIED PROFILE

Are you Christopher C Parker?   Register this Author

Register author
Christopher C Parker

Christopher C Parker

Publications by authors named "Christopher C Parker"

Are you Christopher C Parker?   Register this Author

52Publications

1687Reads

16Profile Views

Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer.

Eur Urol 2019 Dec 23;76(6):719-728. Epub 2019 Aug 23.

The Christie and Royal Salford Hospitals, Manchester, UK; Genito Urinary Cancer Research Group and the FASTMAN Centre of Excellence, Division of Cancer Sciences, The University of Manchester, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838193062
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2019.08.006DOI Listing
December 2019

Compartmental Model for Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer.

Int J Radiat Oncol Biol Phys 2019 Nov 23;105(4):884-892. Epub 2019 Jul 23.

Joint Department of Physics, Royal Marsden NHSFT, Sutton, United Kingdom; The Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.07.022DOI Listing
November 2019

Prostate radiotherapy in newly diagnosed metastatic prostate cancer.

Curr Opin Urol 2019 Nov;29(6):620-628

Genito-Urinary Cancer Research Group and the FASTMAN Prostate Cancer Centre for Excellence, Division of Cancer Sciences, Manchester Cancer Research Centre, The University of Manchester, Manchester.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000675DOI Listing
November 2019

Radiotherapy for metastatic prostate cancer-Authors' reply.

Lancet 2019 09;394(10201):830

Medical Research Council Clinical Trials Unit at University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)31829-XDOI Listing
September 2019

The potential of Ra and F-fluoride imaging to predict bone lesion response to treatment with Ra-dichloride in castration-resistant prostate cancer.

Eur J Nucl Med Mol Imaging 2017 Oct 13;44(11):1832-1844. Epub 2017 Jun 13.

Joint Department of Physics, Royal Marsden NHS Foundation Trust, Downs Rd., Sutton, Surrey, SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-017-3744-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175045PMC
October 2017

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

N Engl J Med 2017 07 3;377(4):338-351. Epub 2017 Jun 3.

From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom; and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1702900DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533216PMC
July 2017

Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.

J Clin Oncol 2017 May 13;35(14):1530-1541. Epub 2017 Mar 13.

Malcolm D. Mason, Cardiff University School of Medicine, Velindre Hospital; Jim Barber, Velindre Cancer Centre, Cardiff; Noel W. Clarke, The Christie and Salford Royal NHS Foundation Trusts; John Logue, Christie Hospital, Manchester; Nicholas D. James, Institute of Cancer and Genomic Sciences; Emilio Porfiri, The Medical School, University of Birmingham; Nicholas D. James, Queen Elizabeth Hospital; Emilio Porfiri, University Hospitals Birmingham NHS Foundation Trust, Birmingham; David P. Dearnaley, Gerhardt Attard, and Christopher C. Parker, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Melissa R. Spears, Alastair W.S. Ritchie, Francesca Schiavone, David Matheson, Robin Millman, Clare Gilson, Mahesh K.B. Parmar, and Matthew R. Sydes, MRC Clinical Trials Unit at UCL, London; William Cross, Leeds Teaching Hospitals NHS Trust, Leeds; Rob J. Jones and J. Martin Russell, University of Glasgow; Rob J. Jones and Jan Wallace, Beatson West of Scotland Cancer Centre, Glasgow; Azman Ibrahim, The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral; Anna Lydon, Torbay District Hospital, Torquay; Ashok D. Nikapota, Sussex Cancer Centre, Brighton; Ashok D. Nikapota, Worthing Hospital, Worthing; Joe M. O'Sullivan, Centre for Cancer Research and Cell Biology, Queen's University, Belfast; Andrew Protheroe, Churchill Hospital, Oxford; Narayanan Nair Srihari, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury; David Tsang, Southend Hospital, Southend-on-Sea; David Tsang, Basildon Hospital, Basildon; John Wagstaff, The South West Wales Cancer Institute; John Wagstaff, Swansea University College of Medicine, Swansea; Catherine Walmsley, Royal Preston Hospital, Preston, United Kingdom; George N. Thalmann, University Hospital; Estelle Cassoly, SAKK Coordinating Center, Berne; and Cyrill A. Rentsch, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.0677DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455701PMC
May 2017

PCP-B class pollen coat proteins are key regulators of the hydration checkpoint in Arabidopsis thaliana pollen-stigma interactions.

New Phytol 2017 Jan 6;213(2):764-777. Epub 2016 Sep 6.

Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath, BA2 7AY, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/nph.14162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215366PMC
January 2017

Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort.

Eur Urol 2016 06 21;69(6):1028-33. Epub 2015 Oct 21.

Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.10.010DOI Listing
June 2016

A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases.

J Nucl Med 2015 Sep 16;56(9):1304-9. Epub 2015 Jul 16.

Joint Department of Physics, Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.157123DOI Listing
September 2015

Reappraisal of glucocorticoids in castrate-resistant prostate cancer.

Asian J Androl 2014 Sep-Oct;16(5):666

Department of Urology and Medicine, Tulane Medical School, Tulane, New Orleans, Louisiana, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/1008-682X.133314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215665PMC
May 2015

Postoperative radiotherapy after radical prostatectomy: let's work together to tackle the known unknowns.

Eur Urol 2014 Jun 27;65(6):1044-5. Epub 2013 Sep 27.

MRC Clinical Trials Unit at UCL, London, UK; Institute of Cancer Research/Royal Marsden Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2013.09.035DOI Listing
June 2014

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.

Authors:
Rosalind A Eeles Ali Amin Al Olama Sara Benlloch Edward J Saunders Daniel A Leongamornlert Malgorzata Tymrakiewicz Maya Ghoussaini Craig Luccarini Joe Dennis Sarah Jugurnauth-Little Tokhir Dadaev David E Neal Freddie C Hamdy Jenny L Donovan Ken Muir Graham G Giles Gianluca Severi Fredrik Wiklund Henrik Gronberg Christopher A Haiman Fredrick Schumacher Brian E Henderson Loic Le Marchand Sara Lindstrom Peter Kraft David J Hunter Susan Gapstur Stephen J Chanock Sonja I Berndt Demetrius Albanes Gerald Andriole Johanna Schleutker Maren Weischer Federico Canzian Elio Riboli Tim J Key Ruth C Travis Daniele Campa Sue A Ingles Esther M John Richard B Hayes Paul D P Pharoah Nora Pashayan Kay-Tee Khaw Janet L Stanford Elaine A Ostrander Lisa B Signorello Stephen N Thibodeau Dan Schaid Christiane Maier Walther Vogel Adam S Kibel Cezary Cybulski Jan Lubinski Lisa Cannon-Albright Hermann Brenner Jong Y Park Radka Kaneva Jyotsna Batra Amanda B Spurdle Judith A Clements Manuel R Teixeira Ed Dicks Andrew Lee Alison M Dunning Caroline Baynes Don Conroy Melanie J Maranian Shahana Ahmed Koveela Govindasami Michelle Guy Rosemary A Wilkinson Emma J Sawyer Angela Morgan David P Dearnaley Alan Horwich Robert A Huddart Vincent S Khoo Christopher C Parker Nicholas J Van As Christopher J Woodhouse Alan Thompson Tim Dudderidge Chris Ogden Colin S Cooper Artitaya Lophatananon Angela Cox Melissa C Southey John L Hopper Dallas R English Markus Aly Jan Adolfsson Jiangfeng Xu Siqun L Zheng Meredith Yeager Rudolf Kaaks W Ryan Diver Mia M Gaudet Mariana C Stern Roman Corral Amit D Joshi Ahva Shahabi Tiina Wahlfors Teuvo L J Tammela Anssi Auvinen Jarmo Virtamo Peter Klarskov Børge G Nordestgaard M Andreas Røder Sune F Nielsen Stig E Bojesen Afshan Siddiq Liesel M Fitzgerald Suzanne Kolb Erika M Kwon Danielle M Karyadi William J Blot Wei Zheng Qiuyin Cai Shannon K McDonnell Antje E Rinckleb Bettina Drake Graham Colditz Dominika Wokolorczyk Robert A Stephenson Craig Teerlink Heiko Muller Dietrich Rothenbacher Thomas A Sellers Hui-Yi Lin Chavdar Slavov Vanio Mitev Felicity Lose Srilakshmi Srinivasan Sofia Maia Paula Paulo Ethan Lange Kathleen A Cooney Antonis C Antoniou Daniel Vincent François Bacot Daniel C Tessier Zsofia Kote-Jarai Douglas F Easton

Nat Genet 2013 Apr;45(4):385-91, 391e1-2

The Institute of Cancer Research, Sutton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2560DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832790PMC
April 2013

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.

Authors:
Ali Amin Al Olama Zsofia Kote-Jarai Fredrick R Schumacher Fredrik Wiklund Sonja I Berndt Sara Benlloch Graham G Giles Gianluca Severi David E Neal Freddie C Hamdy Jenny L Donovan David J Hunter Brian E Henderson Michael J Thun Michael Gaziano Edward L Giovannucci Afshan Siddiq Ruth C Travis David G Cox Federico Canzian Elio Riboli Timothy J Key Gerald Andriole Demetrius Albanes Richard B Hayes Johanna Schleutker Anssi Auvinen Teuvo L J Tammela Maren Weischer Janet L Stanford Elaine A Ostrander Cezary Cybulski Jan Lubinski Stephen N Thibodeau Daniel J Schaid Karina D Sorensen Jyotsna Batra Judith A Clements Suzanne Chambers Joanne Aitken Robert A Gardiner Christiane Maier Walther Vogel Thilo Dörk Hermann Brenner Tomonori Habuchi Sue Ingles Esther M John Joanne L Dickinson Lisa Cannon-Albright Manuel R Teixeira Radka Kaneva Hong-Wei Zhang Yong-Jie Lu Jong Y Park Kathleen A Cooney Kenneth R Muir Daniel A Leongamornlert Edward Saunders Malgorzata Tymrakiewicz Nadiya Mahmud Michelle Guy Koveela Govindasami Lynne T O'Brien Rosemary A Wilkinson Amanda L Hall Emma J Sawyer Tokhir Dadaev Jonathan Morrison David P Dearnaley Alan Horwich Robert A Huddart Vincent S Khoo Christopher C Parker Nicholas Van As Christopher J Woodhouse Alan Thompson Tim Dudderidge Chris Ogden Colin S Cooper Artitaya Lophatonanon Melissa C Southey John L Hopper Dallas English Jarmo Virtamo Loic Le Marchand Daniele Campa Rudolf Kaaks Sara Lindstrom W Ryan Diver Susan Gapstur Meredith Yeager Angela Cox Mariana C Stern Roman Corral Markus Aly William Isaacs Jan Adolfsson Jianfeng Xu S Lilly Zheng Tiina Wahlfors Kimmo Taari Paula Kujala Peter Klarskov Børge G Nordestgaard M Andreas Røder Ruth Frikke-Schmidt Stig E Bojesen Liesel M FitzGerald Suzanne Kolb Erika M Kwon Danielle M Karyadi Torben Falck Orntoft Michael Borre Antje Rinckleb Manuel Luedeke Kathleen Herkommer Andreas Meyer Jürgen Serth James R Marthick Briony Patterson Dominika Wokolorczyk Amanda Spurdle Felicity Lose Shannon K McDonnell Amit D Joshi Ahva Shahabi Pedro Pinto Joana Santos Ana Ray Thomas A Sellers Hui-Yi Lin Robert A Stephenson Craig Teerlink Heiko Muller Dietrich Rothenbacher Norihiko Tsuchiya Shintaro Narita Guang-Wen Cao Chavdar Slavov Vanio Mitev Stephen Chanock Henrik Gronberg Christopher A Haiman Peter Kraft Douglas F Easton Rosalind A Eeles

Hum Mol Genet 2013 Jan 12;22(2):408-15. Epub 2012 Oct 12.

Strangeways Laboratory, Centre for Cancer Genetic Epidemiology, Worts Causeway, Cambridge CB1 8RN, UK.

View Article

Download full-text PDF

Source
http://hmg.oxfordjournals.org/content/22/2/408.full.pdf
Web Search
http://www.hmg.oxfordjournals.org/cgi/doi/10.1093/hmg/dds425
Publisher Site
http://dx.doi.org/10.1093/hmg/dds425DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526158PMC
January 2013

Use of radionuclides in metastatic prostate cancer: pain relief and beyond.

Curr Opin Support Palliat Care 2012 Sep;6(3):310-5

Northern Ireland Cancer Centre, Belfast.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SPC.0b013e328355e082DOI Listing
September 2012

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.

Authors:
Zsofia Kote-Jarai Ali Amin Al Olama Graham G Giles Gianluca Severi Johanna Schleutker Maren Weischer Daniele Campa Elio Riboli Tim Key Henrik Gronberg David J Hunter Peter Kraft Michael J Thun Sue Ingles Stephen Chanock Demetrius Albanes Richard B Hayes David E Neal Freddie C Hamdy Jenny L Donovan Paul Pharoah Fredrick Schumacher Brian E Henderson Janet L Stanford Elaine A Ostrander Karina Dalsgaard Sorensen Thilo Dörk Gerald Andriole Joanne L Dickinson Cezary Cybulski Jan Lubinski Amanda Spurdle Judith A Clements Suzanne Chambers Joanne Aitken R A Frank Gardiner Stephen N Thibodeau Dan Schaid Esther M John Christiane Maier Walther Vogel Kathleen A Cooney Jong Y Park Lisa Cannon-Albright Hermann Brenner Tomonori Habuchi Hong-Wei Zhang Yong-Jie Lu Radka Kaneva Ken Muir Sara Benlloch Daniel A Leongamornlert Edward J Saunders Malgorzata Tymrakiewicz Nadiya Mahmud Michelle Guy Lynne T O'Brien Rosemary A Wilkinson Amanda L Hall Emma J Sawyer Tokhir Dadaev Jonathan Morrison David P Dearnaley Alan Horwich Robert A Huddart Vincent S Khoo Christopher C Parker Nicholas Van As Christopher J Woodhouse Alan Thompson Tim Christmas Chris Ogden Colin S Cooper Aritaya Lophatonanon Melissa C Southey John L Hopper Dallas R English Tiina Wahlfors Teuvo L J Tammela Peter Klarskov Børge G Nordestgaard M Andreas Røder Anne Tybjærg-Hansen Stig E Bojesen Ruth Travis Federico Canzian Rudolf Kaaks Fredrik Wiklund Markus Aly Sara Lindstrom W Ryan Diver Susan Gapstur Mariana C Stern Roman Corral Jarmo Virtamo Angela Cox Christopher A Haiman Loic Le Marchand Liesel Fitzgerald Suzanne Kolb Erika M Kwon Danielle M Karyadi Torben Falck Orntoft Michael Borre Andreas Meyer Jürgen Serth Meredith Yeager Sonja I Berndt James R Marthick Briony Patterson Dominika Wokolorczyk Jyotsna Batra Felicity Lose Shannon K McDonnell Amit D Joshi Ahva Shahabi Antje E Rinckleb Ana Ray Thomas A Sellers Hui-Yi Lin Robert A Stephenson James Farnham Heiko Muller Dietrich Rothenbacher Norihiko Tsuchiya Shintaro Narita Guang-Wen Cao Chavdar Slavov Vanio Mitev Douglas F Easton Rosalind A Eeles

Nat Genet 2011 Jul 10;43(8):785-91. Epub 2011 Jul 10.

The Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.882DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396006PMC
July 2011

The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer.

Eur J Nucl Med Mol Imaging 2011 Jan 10;38(1):7-13. Epub 2010 Aug 10.

Department of Nuclear Medicine and PET, Royal Marsden Hospital, Downs Rd, Sutton, Surrey, SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-010-1576-0DOI Listing
January 2011

Serum micronutrient and antioxidant levels at baseline and the natural history of men with localised prostate cancer on active surveillance.

Tumour Biol 2010 Apr 16;31(2):97-102. Epub 2010 Feb 16.

Department of Clinical Oncology, Ipswich Hospital NHS Trust, Ipswich, Suffolk, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-009-0013-0DOI Listing
April 2010

The relevance of a hypoxic tumour microenvironment in prostate cancer.

BJU Int 2010 Jan 4;105(1):8-13. Epub 2009 Nov 4.

Prostate Research Group, Department of Urology, University of Edinburgh, Western General Hospital, Edinburgh, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2009.08921.xDOI Listing
January 2010

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.

Authors:
Rosalind A Eeles Zsofia Kote-Jarai Ali Amin Al Olama Graham G Giles Michelle Guy Gianluca Severi Kenneth Muir John L Hopper Brian E Henderson Christopher A Haiman Johanna Schleutker Freddie C Hamdy David E Neal Jenny L Donovan Janet L Stanford Elaine A Ostrander Sue A Ingles Esther M John Stephen N Thibodeau Daniel Schaid Jong Y Park Amanda Spurdle Judith Clements Joanne L Dickinson Christiane Maier Walther Vogel Thilo Dörk Timothy R Rebbeck Kathleen A Cooney Lisa Cannon-Albright Pierre O Chappuis Pierre Hutter Maurice Zeegers Radka Kaneva Hong-Wei Zhang Yong-Jie Lu William D Foulkes Dallas R English Daniel A Leongamornlert Malgorzata Tymrakiewicz Jonathan Morrison Audrey T Ardern-Jones Amanda L Hall Lynne T O'Brien Rosemary A Wilkinson Edward J Saunders Elizabeth C Page Emma J Sawyer Stephen M Edwards David P Dearnaley Alan Horwich Robert A Huddart Vincent S Khoo Christopher C Parker Nicholas Van As Christopher J Woodhouse Alan Thompson Tim Christmas Chris Ogden Colin S Cooper Melissa C Southey Artitaya Lophatananon Jo-Fen Liu Laurence N Kolonel Loic Le Marchand Tiina Wahlfors Teuvo L Tammela Anssi Auvinen Sarah J Lewis Angela Cox Liesel M FitzGerald Joseph S Koopmeiners Danielle M Karyadi Erika M Kwon Mariana C Stern Roman Corral Amit D Joshi Ahva Shahabi Shannon K McDonnell Thomas A Sellers Julio Pow-Sang Suzanne Chambers Joanne Aitken R A Frank Gardiner Jyotsna Batra Mary Anne Kedda Felicity Lose Andrea Polanowski Briony Patterson Jürgen Serth Andreas Meyer Manuel Luedeke Klara Stefflova Anna M Ray Ethan M Lange Jim Farnham Humera Khan Chavdar Slavov Atanaska Mitkova Guangwen Cao Douglas F Easton

Nat Genet 2009 Oct 20;41(10):1116-21. Epub 2009 Sep 20.

The Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.450DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846760PMC
October 2009

Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance.

Eur Urol 2008 Dec 7;54(6):1297-305. Epub 2008 Mar 7.

Academic Urology Unit, Institute of Cancer Research, Royal Marsden Hospital, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2008.02.039DOI Listing
December 2008

Outcome of early detection and radiotherapy for occult spinal cord compression.

Radiother Oncol 2007 Dec 26;85(3):469-72. Epub 2007 Nov 26.

Academic Urology Unit, Royal Marsden Hospital, Downs Road, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2007.10.043DOI Listing
December 2007

Long-term effects of a short course of neoadjuvant luteinizing hormone-releasing hormone analogue and radical radiotherapy on the hormonal profile in patients with localized prostate cancer.

BJU Int 2007 Jun;99(6):1380-2

Academic Unit of Radiotherapy and Oncology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2007.06843.xDOI Listing
June 2007

How not to detect prostate cancer.

Lancet Oncol 2007 Feb;8(2):94-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(07)70010-4DOI Listing
February 2007

Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer.

BJU Int 2006 Mar;97(3):476-9

Academic Unit of Radiotherapy and Oncology, and Department of Computing and Information, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2006.06013.xDOI Listing
March 2006

The role of bisphosphonates in the treatment of prostate cancer.

BJU Int 2005 May;95(7):935-8

The Academic Department of Radiotherapy & Oncology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2005.05441.xDOI Listing
May 2005

Technological advances in radiotherapy for the treatment of localised prostate cancer.

Eur J Cancer 2005 Apr;41(6):908-21

Academic Unit of Radiotherapy and Oncology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton SM2 5NG, UK.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095980490500051
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2004.12.028DOI Listing
April 2005